Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Blood|February 25, 1999
Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activitiesM Konopleva, A Mikhail, Z Estrov, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 17, 2013
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLP Y Mak, D H Mak, H Mu, et al.
Cell Death and Differentiation|April 28, 2007
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1Y Tabe, L Jin, R Contractor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
S phase determination in intact colonic crypts by histone H3 messenger RNA in situ hybridization and confocal microscopyH Konishi, G Steinbach, N H Terry, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Oncogene|August 12, 2014
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancerT R Sarkar, V L Battula, S J Werden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Oncogene|June 7, 2011
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathwaysD B Badgwell, Z Lu, K Le, et al.
Leukemia|August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sortingM Varella-Garcia, C J Hogan, L F Odom, et al.
Pageof 31